Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform

OBJECTIVE: To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody) with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients infected with SARS-CoV-2 in the community and at high risk of severe outcomes from covid-19. DESIGN: Observational c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Bang, Green, Amelia C A, Tazare, John, Curtis, Helen J, Fisher, Louis, Nab, Linda, Schultze, Anna, Mahalingasivam, Viyaasan, Parker, Edward P K, Hulme, William J, Bacon, Sebastian C J, DeVito, Nicholas J, Bates, Christopher, Evans, David, Inglesby, Peter, Drysdale, Henry, Davy, Simon, Cockburn, Jonathan, Morton, Caroline E, Hickman, George, Ward, Tom, Smith, Rebecca M, Parry, John, Hester, Frank, Harper, Sam, Mehrkar, Amir, Eggo, Rosalind M, Walker, Alex J, Evans, Stephen J W, Douglas, Ian J, MacKenna, Brian, Goldacre, Ben, Tomlinson, Laurie A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667468/
https://www.ncbi.nlm.nih.gov/pubmed/36384890
http://dx.doi.org/10.1136/bmj-2022-071932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667468/
https://www.ncbi.nlm.nih.gov/pubmed/36384890
http://dx.doi.org/10.1136/bmj-2022-071932

Ejemplares similares